https://insights.citeline.com/scrip/r-and-d/pipeline-watch/pipeline-watch-seven-approvals-and-a-phase-iii-readout-EJT4GEC4EZEHPC3ZSY6XYVZUOA/2026-04-20T22:32:12.074Zalways0.5Insightsen2026-04-20T22:32:12.074Zhttps://insights.citeline.com/resizer/mwgLSJZ0a5U0mjF6EXfMd2TDtec=/cloudfront-us-east-1.images.arcpublishing.com/norstella/R4HJYLHCRZMUHILQHESB7CGVPA.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/astrazeneca-builds-copd-case-for-tozorakimab-with-third-positive-phase-iii-trial-BETMCN7AVNFV5KK5INJB7QYJ7M/2026-04-20T22:31:57.678Zalways0.5Insightsen2026-04-20T22:31:57.678Zhttps://insights.citeline.com/resizer/Q0zJt-8rDzLLKXgix2US-wKAbCE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/NMUMZBGGLZGA3H5CCDENJVMH4A.jpghttps://insights.citeline.com/scrip/business/strategy/fresh-off-phase-iii-revolution-presents-positive-frontline-daraxonrasib-data-WFQ3JHMFS5H5PD4ETE4JG3QDSA/2026-04-20T22:31:11.187Zalways0.5Insightsen2026-04-20T22:31:11.187Zhttps://insights.citeline.com/resizer/-xJZbNWbQPHwQSmGCAz0zst8r7c=/cloudfront-us-east-1.images.arcpublishing.com/norstella/RCGW3INYMZB2PCP2SSN3KKGAPE.jpghttps://insights.citeline.com/scrip/business/deals/lilly-adds-to-in-vivo-car-t-capabilities-with-kelonia-buyout-7PFEOZOPOVBTPGZCXCXGUYHYFI/2026-04-20T22:30:43.367Zalways0.5Insightsen2026-04-20T22:30:43.367Zhttps://insights.citeline.com/resizer/OItP7HXvkwSyTVTzB4GbAPqlW3o=/cloudfront-us-east-1.images.arcpublishing.com/norstella/4VUAZHW63FAOHABCZCKDF45W5U.jpghttps://insights.citeline.com/scrip/therapeutic-category/blood-and-clotting/novo-nordisk-shows-sickle-cell-efficacy-advantage-over-agioss-mitapivat-IHLWRLHPMJC4JO2INPJJZYI7YM/2026-04-20T22:30:24.843Zalways0.5Insightsen2026-04-20T22:30:24.843Zhttps://insights.citeline.com/resizer/jVNvvxvbtu8IxSbpHt74mpWJXes=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ZYHRRQ7OAZGZZJA7ZTJDKF3SFM.jpghttps://insights.citeline.com/pink-sheet/pathways-and-standards/review-pathways/us-fda-wants-feedback-on-cnpvs-start-by-releasing-the-reviews-GI3E266LSRD27OANOL4N4UYGO4/2026-04-20T22:28:31.269Zalways0.5Insightsen2026-04-20T22:28:31.269Zhttps://insights.citeline.com/resizer/StcnuYuvxQHqWo5UXbCJ2CdnDQw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/U53ZN3FPKZETTDYDOAHFYID4WI.jpghttps://insights.citeline.com/hbw-insight/beauty/policy-and-regulation/vocs-next-cosmetics-target-consumer-reports-finds-methylene-chloride-in-hair-dye-VEX63ZMUHRCRDJEGIVSV34YVLE/2026-04-20T22:13:13.219Zalways0.5Insightsen2026-04-20T22:13:13.219Zhttps://insights.citeline.com/resizer/hAgBNVzLqQ7NWC6DWO-1tvW1KOA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/2IBQMIU63NAT5OI3PFFZ6HWPZI.jpghttps://insights.citeline.com/medtech-insight/market-access/medical-device-repair-controversy-back-in-play-OBTXKQL4GBBA5I5S2SLXQ6GJXA/2026-04-20T21:54:24.578Zalways0.5Insightsen2026-04-20T21:54:24.578Zhttps://insights.citeline.com/resizer/MdOAjj8-7V_0SiXq8lVzjkgypUk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XPB6SZZNEVEP3DFRIU7IYAVPKQ.jpghttps://insights.citeline.com/medtech-insight/business/deals/medtronic-adds-ffrangio-to-cardiovascular-arsenal-in-585m-cathworks-acquisition-N2A4FYQHJJH4HBTSS3NNE6BECA/2026-04-20T20:27:07.32Zalways0.5Insightsen2026-04-20T20:27:07.32Zhttps://insights.citeline.com/resizer/DIOHbWe8RnL3Vr72C4ftQoHxEPE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/KXV77PQ6LNAB5C3NI55FN75ZGA.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/compliance/guidance/fda-proposes-to-forego-premarket-review-for-certain-cdc-approved-respirators-2WPEK37CAFALVL5F4R5XKXQUVE/2026-04-20T19:57:04.657Zalways0.5Insightsen2026-04-20T19:57:04.657Zhttps://insights.citeline.com/resizer/_LcvQ0dm4EEwR_oFTXoQZZ-Zq58=/cloudfront-us-east-1.images.arcpublishing.com/norstella/WMJKE2AQOBGBNMU7SC43OXT3LE.jpghttps://insights.citeline.com/scrip/r-and-d/boehringer-ingelheims-ai-investment-is-welcome-news-for-the-uk-EY2OFNRCDBDGTFTWOGW3PA3YKY/2026-04-20T17:12:54.891Zalways0.5Insightsen2026-04-20T17:12:54.891Zhttps://insights.citeline.com/resizer/eyddDxZZ7RiKUOtX2JKFfwYnLRg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/EXCJBDCJDZFFJCWNYOO6EOQ72U.jpghttps://insights.citeline.com/medtech-insight/business/financing/harbinger-raises-100m-presents-new-data-for-cancer-tests-at-aacr-P7KJIGUFLJHJTCILZJLDTTTYOM/2026-04-20T16:35:39.519Zalways0.5Insightsen2026-04-20T16:35:39.519Zhttps://insights.citeline.com/resizer/iULnyrwS6SvKEA6zFifWsMePxfk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/2AAT2DB2D5MOXAPNATZMKM6EXI.jpghttps://insights.citeline.com/in-vivo/business-strategy/ai/data-governance-do-you-have-what-it-takes-to-realize-the-promise-of-ai-ELTPTZVWUZHDNPBQ4DZEYFNHMU/2026-04-20T16:20:18.736Zalways0.5Insightsen2026-04-20T16:20:18.736Zhttps://insights.citeline.com/resizer/YpP7dEU1-oLLisr_5Nm0K4Y6Lbk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/4XKXCONLFRFURDGH62Z5RGVSZ4.jpghttps://insights.citeline.com/generics-bulletin/products/generics/ani-bolsters-us-generics-offering-with-two-launches-EFVVZ5HBPBBT5A5R3W7AK5XFVE/2026-04-20T15:38:03.052Zalways0.5Insightsen2026-04-20T15:38:03.052Zhttps://insights.citeline.com/resizer/eujQlg1cPGxAuC_QRuvBZ1i5AOg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BDLYPTKWAVHZZA33VLVSCTIXEM.jpghttps://insights.citeline.com/generics-bulletin/business/deals/lupin-follows-sandoz-sun-in-antitrust-suit-settlement-30m-for-humana-WXFYBS72EFBTRFTQVA6ONDJE2A/2026-04-20T14:42:23.348Zalways0.5Insightsen2026-04-20T14:42:23.348Zhttps://insights.citeline.com/resizer/Qw8fKf3ie5S6CM-W5cqBuSrsuBk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/SBMOJ7GT5NBDPKCHF3JJI2ESCI.jpghttps://insights.citeline.com/in-vivo/innovation/another-one-bites-the-dust-iterum-shuts-shop-as-antibiotic-woes-drag-on-7ZNPKRP2BNA3HDEYDDT3WT42BY/2026-04-20T14:33:28.333Zalways0.5Insightsen2026-04-20T14:33:28.333Zhttps://insights.citeline.com/resizer/I11mG5VC9GSYmd_f5a2tej9gFS0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/M4NGDPTNBNC25EQMIXTODHATSE.jpghttps://insights.citeline.com/generics-bulletin/products/generics/glp-1s/reddys-brazil-setback-signals-tougher-semaglutide-path-HLTHP2B7CRF3DN2GWRS4ZEMHMI/2026-04-20T14:24:08.621Zalways0.5Insightsen2026-04-20T14:24:08.621Zhttps://insights.citeline.com/resizer/9xmDBHT7PFxED6_ztf5e6UyqQ-I=/cloudfront-us-east-1.images.arcpublishing.com/norstella/CHLGT2YGVJPLXFC7MYNIV5UWH4.jpghttps://insights.citeline.com/pink-sheet/product-reviews/eu-chmp/new-eu-filings-TB5JGPOFXRCRNFSTQDMLU6ODZA/2026-04-20T14:07:42.827Zalways0.5Insightsen2026-04-20T14:07:42.827Zhttps://insights.citeline.com/resizer/qr4HqLM3X7pfzfb_UShZ54G3B6w=/cloudfront-us-east-1.images.arcpublishing.com/norstella/R2VDCMSQWVJTVG72SZJTX6TEA4.jpghttps://insights.citeline.com/pink-sheet/legislation/eu-pharma-legislation-reform/eu-pharma-reform-supply-obligations-burdensome-for-smes-warns-eucope-HFOHHJJ6ARDXPHAJOZE3YQ5QC4/2026-04-20T14:05:01.598Zalways0.5Insightsen2026-04-20T14:05:01.598Zhttps://insights.citeline.com/resizer/MAJL4d1J7TWLMi0a-3XPMEVUAOE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/TMVVSSRQKVBIFI5DA22G7C3XN4.jpghttps://insights.citeline.com/in-vivo/leadership/rising-leaders/in-vivos-2026-rising-leaders-at-a-glance-2S7BIEWE4JD75JKTCLJY3KZXJU/2026-04-20T13:58:36.031Zalways0.5Insightsen2026-04-20T13:58:36.031Zhttps://insights.citeline.com/resizer/qUL2KwheSy8OVGjzwegnRzV2440=/cloudfront-us-east-1.images.arcpublishing.com/norstella/UPM263F335AMNDWRUYECR4FGZI.pnghttps://insights.citeline.com/in-vivo/leadership/in-vivos-2026-rising-leaders-P65JE4EAZ5CDDAW4ABFKNABFKY/2026-04-20T13:45:48.731Zalways0.5Insightsen2026-04-20T13:45:48.731Zhttps://insights.citeline.com/resizer/Bkq1T_WCg0g9lUN8trx1sIzkICE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/6UBHVQ6UNVE6LL54ST7GOKUATI.jpghttps://insights.citeline.com/pink-sheet/regional-comparisons/indias-trademark-regime-regulatory-blind-spot-patient-safety-and-case-laws-to-heed-K3VYMWZACVCWTJHYRLKWKEWUME/2026-04-20T11:30:36.692Zalways0.5Insightsen2026-04-20T11:30:36.692Zhttps://insights.citeline.com/resizer/AfOJFvOAjTnn7soGAUXV7hjdxIs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HSKRK2R5PJDQ7JT437JM5TMT5Y.jpghttps://insights.citeline.com/medtech-insight/business/financing/medtronic-pulnovo-join-forces-on-pulmonary-denervation-after-100m-financing-2HFGWRLAIFEJ7JGUTCTBPBWHVM/2026-04-20T11:21:11.8Zalways0.5Insightsen2026-04-20T11:21:11.8Zhttps://insights.citeline.com/resizer/Jnaw9g32HWAYFjBJIeKYIwFBEQM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QLUX5VLONJMVRGTPG7RNHKIXPI.jpghttps://insights.citeline.com/pink-sheet/advanced-technologies/cell-and-gene-therapies/excipients-as-strategic-enablers-of-advanced-therapies-OYPPXUBQIBAMXLIOUV2PUNWK6E/2026-04-20T08:58:38.828Zalways0.5Insightsen2026-04-20T08:58:38.828Zhttps://insights.citeline.com/resizer/QoiiO0SYsAQ8VfC5pudZRXPiPi8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/KNEFMJLDCNEKLDYMER52PX5ME4.pnghttps://insights.citeline.com/scrip/business/legalandip/lupin-follows-sandoz-sun-in-antitrust-suit-settlement-30m-for-humana-XUQC7QPY7NCHHANDFIUT57Z6WQ/2026-04-20T08:40:55.161Zalways0.5Insightsen2026-04-20T08:40:55.161Zhttps://insights.citeline.com/resizer/Qw8fKf3ie5S6CM-W5cqBuSrsuBk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/SBMOJ7GT5NBDPKCHF3JJI2ESCI.jpghttps://insights.citeline.com/in-vivo/manufacturing/the-chemist-who-wants-to-reprogram-drug-discovery-X3XWVRMRM5GFRELO4J55RTUGDQ/2026-04-20T08:27:38.443Zalways0.5Insightsen2026-04-20T08:27:38.443Zhttps://insights.citeline.com/resizer/0D1aGd_7y23YZ6EBW2sfQZtj2dw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/NY2DUCINEBEQZDBSBTEN2JEV7Q.jpghttps://insights.citeline.com/scrip/leadership/interviews/alphamab-pursues-differentiated-approach-to-next-gen-adcs-455SCBRW4JFKNB2PVPAHV473XU/2026-04-20T07:53:45.613Zalways0.5Insightsen2026-04-20T07:53:45.613Zhttps://insights.citeline.com/resizer/xeq8jcfHKag1S_VbRMt51dKCKSg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/N4JB2T4W4NMX3C22VRPXSTJGYE.jpghttps://insights.citeline.com/companies/mirata-biopharma2026-04-20T00:05:33.632Zalways0.5Insightsen2026-04-20T00:05:33.632Zhttps://insights.citeline.com/companies/fivephusion2026-04-20T00:05:27.879Zalways0.5Insightsen2026-04-20T00:05:27.879Zhttps://insights.citeline.com/companies/biofarm2026-04-20T00:05:21.635Zalways0.5Insightsen2026-04-20T00:05:21.635Zhttps://insights.citeline.com/companies/bene-pharmachem2026-04-20T00:05:15.658Zalways0.5Insightsen2026-04-20T00:05:15.658Zhttps://insights.citeline.com/companies/formune2026-04-20T00:05:09.574Zalways0.5Insightsen2026-04-20T00:05:09.574Zhttps://insights.citeline.com/companies/avita2026-04-20T00:05:03.859Zalways0.5Insightsen2026-04-20T00:05:03.859Zhttps://insights.citeline.com/companies/avero-diagnostics2026-04-20T00:04:57.41Zalways0.5Insightsen2026-04-20T00:04:57.41Zhttps://insights.citeline.com/companies/eyecure-therapeutics-inc2026-04-20T00:04:51.46Zalways0.5Insightsen2026-04-20T00:04:51.46Zhttps://insights.citeline.com/companies/mapreg2026-04-20T00:04:45.442Zalways0.5Insightsen2026-04-20T00:04:45.442Zhttps://insights.citeline.com/companies/libera-bio-sl2026-04-20T00:04:40.053Zalways0.5Insightsen2026-04-20T00:04:40.053Zhttps://insights.citeline.com/companies/gaba-therapeutics-inc2026-04-20T00:04:30.552Zalways0.5Insightsen2026-04-20T00:04:30.552Zhttps://insights.citeline.com/companies/biomup-sa2026-04-20T00:04:18.613Zalways0.5Insightsen2026-04-20T00:04:18.613Zhttps://insights.citeline.com/companies/microtech-medical-hangzhou-co-ltd2026-04-20T00:04:06.735Zalways0.5Insightsen2026-04-20T00:04:06.735Zhttps://insights.citeline.com/companies/sk-pharma-group2026-04-20T00:03:54.372Zalways0.5Insightsen2026-04-20T00:03:54.372Zhttps://insights.citeline.com/companies/knight-diagnostic-laboratories2026-04-20T00:03:42.414Zalways0.5Insightsen2026-04-20T00:03:42.414Zhttps://insights.citeline.com/companies/bitbio2026-04-20T00:03:30.26Zalways0.5Insightsen2026-04-20T00:03:30.26Zhttps://insights.citeline.com/companies/endocellutions-llc2026-04-20T00:03:18.068Zalways0.5Insightsen2026-04-20T00:03:18.068Zhttps://insights.citeline.com/companies/femtogenix-ltd2026-04-20T00:03:06.118Zalways0.5Insightsen2026-04-20T00:03:06.118Zhttps://insights.citeline.com/companies/az-pharmaceutical-inc2026-04-20T00:02:54.234Zalways0.5Insightsen2026-04-20T00:02:54.234Zhttps://insights.citeline.com/companies/aus-bio-ltd2026-04-20T00:02:42.283Zalways0.5Insightsen2026-04-20T00:02:42.283Zhttps://insights.citeline.com/companies/sofar-spa2026-04-20T00:02:30.185Zalways0.5Insightsen2026-04-20T00:02:30.185Zhttps://insights.citeline.com/companies/europharm2026-04-20T00:02:18.282Zalways0.5Insightsen2026-04-20T00:02:18.282Zhttps://insights.citeline.com/companies/roxro-pharma-inc2026-04-20T00:02:06.031Zalways0.5Insightsen2026-04-20T00:02:06.031Zhttps://insights.citeline.com/companies/biocore-medical-technologies-inc2026-04-20T00:01:54.229Zalways0.5Insightsen2026-04-20T00:01:54.229Zhttps://insights.citeline.com/companies/biocurity-pharmaceuticals-inc2026-04-20T00:01:42.184Zalways0.5Insightsen2026-04-20T00:01:42.184Zhttps://insights.citeline.com/companies/epirus-biopharmaceuticals-inc2026-04-20T00:01:30.058Zalways0.5Insightsen2026-04-20T00:01:30.058Zhttps://insights.citeline.com/companies/atigen-cell2026-04-20T00:01:18.101Zalways0.5Insightsen2026-04-20T00:01:18.101Zhttps://insights.citeline.com/companies/develogen2026-04-20T00:01:07.244Zalways0.5Insightsen2026-04-20T00:01:07.244Zhttps://insights.citeline.com/companies/biosidus-sa2026-04-20T00:00:53.98Zalways0.5Insightsen2026-04-20T00:00:53.98Zhttps://insights.citeline.com/companies/medimmune-llc2026-04-20T00:00:41.963Zalways0.5Insightsen2026-04-20T00:00:41.963Z